From: Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand
Variables | HCM-Related Death | MACEs | ||||
---|---|---|---|---|---|---|
Univariate Analysis | Univariate Analysis | Multivariate Analysis | ||||
Hazard Ratio | p Value | Hazard Ratio | p Value | Hazard Ratio | p Value | |
Age ≥ 65 years | 0.78 | 0.66 | 2.01 | 0.01* | 1.66 | 0.09 |
Female | 1.24 | 0.65 | 2.33 | < 0.01* | 1.66 | 0.11 |
BSA ≤ 1.5 m2 | 2.03 | 0.11 | 1.97 | 0.01* | 1.70 | 0.08 |
NYHA III-IV | 1.36 | 0.58 | 3.00 | < 0.01* | 1.27 | 0.55 |
Heart rate > 90/min | 2.56 | 0.07 | 3.05 | < 0.01* | 2.18 | 0.04** |
Family History of SCD | 0.88 | 0.73 | 1.03 | 0.94 | Â | Â |
AF on ECG | 1.83 | 0.28 | 2.05 | 0.05 | 2.81 | 0.01** |
Heart failure at presentation | 1.32 | 0.59 | 3.44 | < 0.01* | 2.93 | < 0.01** |
Maximal septal thickness ≥ 25 mm | 1.15 | 0.80 | 0.97 | 0.94 |  |  |
LVEF < 60% | 0.60 | 0.36 | 1.75 | 0.12 |  |  |
Septal reductive therapy | 0.58 | 0.59 | 1.12 | 0.65 | Â | Â |